TriloTalk

Episode 45: Inside NEXT Medical Writing Automation: The Decisions You Don’t See

AI is transforming medical writing, but how do you build a solution that's trusted enough to support high-stakes work? In this episode of TriloTalk, Lisa Chamberlain

Episode 44: 10 minutes, 5 Medical Writing Lessons

Short on time? We’ve condensed five valuable medical writing lessons into one quick 10-minute episode. We explore mentorship, purposeful writing, patient-focused communic

Episode 43: More Than Words: The Real Work of Health Literacy

This episode of TriloTalk explores how health literacy goes far beyond simplifying language. It requires consistency, testing, and truly meeting patients where they are.

Episode 42: Journey to Leadership in Medical Writing

What does it really take to move into leadership in medical writing? Nidhi Johal, Medical Writing Manager of North America, and Kleopatra Kouroupaki, Senior Medical Writi

Episode 41: Breaking Down the One-Click Submission Dream

Everyone is talking about “one-click AI,” but is it real or just a conference buzzword? In this episode of TriloTalk, Lisa Chamberlain James, Senior Partner at Trilogy, a

Episode 40: The CDx Files: Decoding Companion Diagnostic Devices

This episode of TriloTalk explores companion diagnostics and what makes them medical devices. Join Julia Forjanic Klapproth, Senior Partner at Trilogy, Laura Collada, Sen

Episode 39: Unlocking the Power of Storytelling in Medical Writing: the PRISM Framework

Humans communicate through stories and medical writers help teams crystallize the story out of the data: this is the essence of what they bring to the table. Join Julia F

Episode 38: Explaining the Evidence - Using AI for Lay Summaries of Clinical Trial Results

For TriloTalk episode 38, Lisa Chamberlain James, Senior Partner at Trilogy, and Sudipta Chakraborty, Head of Literacy & Plain Language Center of Excellence at Biogen, ta

Episode 37: Primer on Writing for Drug-Delivery Systems

TriloTalk episode 37 focuses on a specific type of medical device, the drug-delivery system. Writing for drug-delivery systems is all about being fluent in two languages

Episode 36: Being Transparent About Clinical Trial Transparency

Clinical trial transparency is a delicate balance of getting the right data to the right resources at the right time. Senior Partner Lisa Chamberlain James sits down with

Episode 35: Introducing the AMWA Apprentice Program Framework – A step-by-step guide to training medical writers

The demand for experienced medical writers is outpacing the availability of experienced writers. In TriloTalk episode 35, Julia Forjanic Klapproth, Senior Partner at Tril

Episode 34: AI Agents - the future that's being used today!

For episode 34 of the TriloTalk podcast, Lisa Chamberlain James, Senior Partner at Trilogy, sits down with the AI Agent expert Nikesh Shah, VP and Global Head, Generative

Episode 33: Are Medical Devices from Venus and Pharmaceuticals from Mars? Important things to know when writing for medical devices.

This episode focuses on writing for medical devices. Playing Sherlock Holmes, conducting usability studies, following regulations, working closely with the manufacturers

Episode 32: Engaging the Clinical Trial Participant – using Plain Language in Informed Consent Forms

The Informed Consent Form is a participant’s first impression of a clinical trial so Lisa Chamberlain James and Ros Cheetham sit down to discuss how to make it the best i

Episode 31: What You Need to Know About AI Agents & Medical Writing

Join Julia Forjanic Klapproth as she gives a useful overview of what everyone is talking about these days – AI agents. You’ll hear about the benefits they bring and their

Episode 30: Exploring the Role of Women in Science  

It’s International Day of Women and Girls in Science! To celebrate, TriloTalk episode 30 is a conversation with Trilogy’s two female Senior Partners discussing what spark

Episode 29: What's Hot & What's Not for Regulatory Medical Writing in 2025

The rapidly growing industry of regulatory medical writing calls for a 2025 prediction podcast! Listen up for “What’s Hot and What’s Not” from our experts Lisa Chamberlai

Episode 28: Exploring the Past, Present and Future of Orphan Drugs

Long time friends and industry colleagues, Lisa Chamberlain James with Trilogy and Cheryl Roberts with BioMarin Pharmaceutical sit down to discuss orphan drugs. They go o

Episode 27: Clinical Overviews - What are they & why are they so important?

Join Julia Forjanic Klapproth, Barbara Boggetti, and Bhawna Basin as they take a closer look into Clinical Overviews. Since many agree it’s one of the most interesting do

Episode 26: The Future of Lay Summaries - Leveraging AI for Patient-Friendly Language

Welcome back to TriloTalk! In this episode, Lisa Chamberlain James from Trilogy and Vladimir Penkrat and Ritesh Dogra from Indegene dive into the role and future of lay s